Fortera Capital

Fortera Capital is a professional private equity and venture capital fund management institution based in Shanghai, China, primarily initiated by Shanghai State-owned Capital Investment Co., Ltd (SSCI). The firm manages over $4 billion in assets and focuses on technology-driven innovation across healthcare, advanced manufacturing, and the digital economy. In the life sciences sector, Fortera Capital is a prominent investor in high-impact areas such as proton therapy systems, AI-driven drug discovery, and translational medicine. The firm leverages a robust network of industrial partners, including SAIC Group and CATL, to provide strategic advisory and resource integration for its portfolio companies. Fortera Capital also actively fosters academic-industry collaborations, notably partnering with the University of Hong Kong (HKUMed) to support the commercialization of groundbreaking medical research.